safe prescribing week 3 – amino glycosides + electrolytes dr ian coombes, senior clinical lecturer...

54
Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy Safe Medication Practice Unit, Queensland Health The University of Queensland

Upload: adrian-tisdel

Post on 14-Dec-2015

216 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Safe PrescribingWeek 3 – Amino

glycosides + electrolytes

Safe PrescribingWeek 3 – Amino

glycosides + electrolytes

Dr Ian Coombes,

Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Safe Medication Practice Unit, Queensland Health

Dr Ian Coombes,

Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Safe Medication Practice Unit, Queensland Health

The University of Queensland

Page 2: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Objectives

• Principles of once daily Aminoglycoside dosing and avoiding toxicity

• Key messages about analgesia use

Page 3: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Gentamicin Revision

• Gram negative bactericidal agent• Excellent anti-pseudomonal cover• Once daily dosing benefits vs tds or bd:

- high peak level – excellent distribution- post antibiotic effect (>24-36 hours) - reduced monitoring and administration- reduced nephro and ototoxicity- easier monitoring (10-12 hours post dose)

Page 4: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Severe risks of nephrotoxicity and ototoxicity

• Mrs HR• 78 years, wt 57kg• Admitted to outlying hospital acute exacerbation COPD• Baseline Cr 80mol/L• Charted gentamicin 160mg daily for 5/7• CrCl = 45ml/min

Page 5: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Date Gent Dose Level Cr Urea3/6 0.08 8.55/6 160mg6/6 160mg 0.11 15.57/6 160mg 6.2 0.138/6 160mg 9.0 0.17 21.99/6 160mg10/6 ceased 16.9 0.22 28.311/612/6 7.8 0.36 35.013/6 0.3914/6 0.41 33.615/6 0.5016/6 0.59 38.917/6 0.65 40.6

Page 6: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy
Page 7: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

• 21/6 Gent level still 1.4!!!!

• 23/6 complaining of dizziness, unsteady feeling, vestibular symptoms, vomiting

• 1/7 Cr 0.21 recovering

Page 8: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Aminoglycoside dosing and Monitoring

Case continued…

Day 3:• Mr AD (67yrs) has now developed sever hospital acquired

pneumonia • Ward round decisions

- start gentamicin once a day dose as per levels each night at 20:00 recall patient weighs 70 kg creatinine has improved (now 140 micro mole/l)

- start Co-Amoxiclav 1.2g IV q8h

Page 9: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy
Page 10: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Creatinine Clearance• Do NOT use eGFR provided by AusLab(calculated using standard 70 kg patient can lead to over-dosing)

• Recall Cockcroft-Gault Formula:

CrCl (mL/min) = [140-age (years)] * ideal weight (kg) [0.814 * serum creatinine

(micromol/L)]

{♀ * 0.85 }If patient 70 kg, 67 y.o. with serum creat~140micromol/L:

CrCl ≈ 42 mL/min (140-67 X 70) / (0.814 x 140)

Page 11: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Calculating first dose gent

Page 12: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Gentamicin Dose Adjustment

Day 4: gentamicin level = 2.5

(taken 08:00, 12 hrs post dose)• The initial dose given in emergency department

was 280mg (4mg/kg x approx 70kg)

Prescribe new gentamicin dose based on level

Page 13: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

2.5

Page 14: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Adjusting doses of gentamicin

Page 15: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Gentamicin Dose Adjustment

• Level at 12 hours = 2.5 (ideal = < 2)

• New Dose = Level Wanted (mg/L) x Dose Given (mg)Level Achieved (mg/L)

In this case: (1.5/2.5) x 280 = 168 mg• round down to 160 (nearest multiple of 40 mg)

- amps = 40 mg/mL

Page 16: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

When NOT to take levels

• Do not take levels if:• Stat dose • Or• Patient has Normal renal function and is only

receiving 1 or 2 doses ie prophylactic

Page 17: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Variable Dose MedicationDrug Level and Time Taken

Dose Time and Actual Time Given

Page 18: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Use in moderate to sever renal function

• Where ever possible withhold other nephrotoxic drugs and ensure no other altenative

• Ie unavoidable use of gentamicin:• Requires extended dose intervals 36, 48 or 96

hours• Effectively daily levels wait til < 1.0mmol/l

then dose again

Page 19: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Gentamicin FAQs• Patient returns from OT, septic, at 4 p.m.?

- dose now - get level 8 a.m. (difficult to get bloods during night)

if level < 0.5, clearance satisfactory• Patient in ED at 4 a.m. with severe pneumonia?

- give standard dose now; dose again at 8 p.m.• Level low but adequate dose? (patient ok clinically)

- dose 4-5mg/kg has long post antibiotic effect- don’t increase

• If in doubt, CHECK!- Registrar; clinicial pharmacists; ID team

Page 20: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Gentamicin Ordering key messages

• If elderly (renal impaired) is there an alternative safer drug?• Do not write as a regular medication – prescribe dose for regular

dosing after levels available• Dose according to gentamicin level• Use aminoglycoside dosing guides

- these notes www.wiki.tox.org.2.17 safe prescribing• Try to prescribe in multiples of 40mg (ampoule contains

80mg/2mL = 40mg/mL)• Where possible, dose at a time that allows level to be taken on

next day’s blood round

Page 21: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Questions?

Page 22: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Introduction to PrescribingAnalgesia and Pain Relief

Presented by: [insert presenter name here]

Page 23: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

You have been asked to write up a patient’s analgesia…

What patient factors do you need to consider?

Page 24: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Patient Assessment

Goal to individualise analgesic therapy

Assess patient characteristics:

- indication for analgesia- age, sex, weight- culture - vital signs - allergies/ADRs- opioid tolerance

- respiratory status - renal/hepatic function- other medical co-morbidities- mental state - other Rx - availability of oral/rectal routes

Page 25: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

WHO Analgesic Ladder (ideally fro chronic pain)

Level 1: Non opioid/adjuvant(paracetamol; NSAIDs; amitriptyline; local anaesthetics)

Level 2: Weak opioid + non-opioid

Level 3: Strong opioid +/- non-opioid/adjuvant1 2 3

NOT ACCEPTED- Use Multimodal Analgesia

Page 26: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

DRUGS

PAIN TYPE

Nociceptivee.g. fracture

Neuropathiceg neuralgia

Inflammatory e.g. rheumatoid arthritis

Paracetamol Effective when taken regularly at max. dose

Less effective Effective, but not anti-inflammatory

Opioids Effective May be effective(agent + dose)

May be effective (depends on dose)

NSAIDs Effective Not effective Effective

TCAs, parenteral, local anaesthetics antiepileptic

Rarely used (clonidine may be effective as adjunct)

May be effective

Rarely used (may be effective as adjunct)

Adapted from Table 3-1, Australian Medicines Handbook

Page 27: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

NSAIDs- Adverse EffectsSide effects Cautions

• hypersensitivity/allergy

• GI (GORD/PUD)

• platelet inhibition

• sodium retention, oedema

• renal toxicity

• hepatic toxicity

Page 28: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

NSAIDs- Adverse EffectsSide effects Cautions

• hypersensitivity/allergy - asthma

• GI (GORD/PUD) - GI bleeding/ulceration

• platelet inhibition - coagulation disorders- warfarin therapy

• sodium retention, oedema - hypertension- cardiac failure- ACEI/ARA/diuretics

• renal toxicity - renal impairment- gentamicin therapy

• hepatic toxicity - hepatic impairment

Page 29: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

NSAIDs – Caution!

Major cause of ADEs and hospital admissions

use lowest effective dose for shortest possible time use paracetamol as alternative or to reduce NSAID dose COX-2 inhibitors

- similar adverse effects to non-selective- increase risk of thrombotic events (stroke; MI)!

little difference in efficacy between NSAIDs avoid aspirin < 18 yrs in viral illness (Reye’s syndrome) elderly - increased risk of adverse effects

Continue only if effective. Avoid if possible!

Page 30: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Potential Adverse Effects of Opioids?

Page 31: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

respiratory depression sedation nausea and vomiting confusion hypotension; bradycardia pruritus constipation / ∆ gut motility urinary retention

Opioids – Adverse Effects

Page 32: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Opioids – Precautions

hypotension, shock concomitant CNS depression impaired respiration /↓ respiratory reserve elderly hepatic impairment renal impairment epilepsy/recognised seizure risk biliary colic or surgery phaeochromocytoma

Page 33: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Regular vs PRN Analgesia

regular analgesia is better in setting of continuous pain PRN only if pain intermittent and unpredictable in most settings, pain is predictable problems with using only PRN analgesia

- dose prescribed by Dr/administered by nurse- patients don’t ask for medication

inadequate or infrequent dosing → unrelieved pain keeping up with pain is easier than catching up with pain prn dose = 1/6 →1/12 total regular daily dose

Page 34: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Key Messages individualise analgesic therapy choose analgesics judiciously use multimodal analgesia regular pain monitoring is critical to outcomes regularly review and revise analgesic doses adjust regular dose according to breakthrough usage anticipate and manage analgesic-associated adverse

events avoid NSAIDs – major cause of morbidity/mortality! avoid tramadol, dextropropoxyphene, pethidine

Page 35: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Electrolyte Objectives

• Fluid requirements• Common error traps• Electrolyte requirements • Key messages for safe electrolyte

prescribing

Page 36: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Maintenance Fluid for “Standard” Patient

–70 kg–euvolaemic–no electrolyte derangements–not septic–normal cardiac and renal function–no additional ongoing fluid losses

Page 37: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Sodium Glucose Potassium

Daily Requirement 2 mmol/kg >100G 1 mmol/kg

0.9% NaCl 1L

(Normal Saline) +/- 20/40 mmol KCl/l

150 mmol 00, 20 or 40

mmol

4% glucose & 0.18% NaCl 1L

30 mmol 40G 0

3.3% glucose & 0.3% NaCl +/-

20/40 mmol KCl 1L50 mmol 33G

0, 20 or 40 mmol

Page 38: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Risks of Having IV Line

• Infection– Time and effort to re-site every 48 hours

• Immobility • Thrombophlebitis• Direct costs of consumables• Overdosing of fluids and electrolytes

Page 39: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Key Messages IV Fluid Ordering

• Supply orally if possible• Assess current fluid status-wet / dry / ‘just right’? -how do you tell?

• Review fluid balance chart• Assess ongoing requirements and losses• Reassess fluid status at least daily

Page 40: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Potassium

• What is normal?• Where do you lose it from?• How much do you need?• How can you replace it?• Routes of administration? • How fast can you replace it?• Quantities?• What goes wrong?

Page 41: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Potassium

• Normal serum K+ = 3.8-4.9 mmol/L• Daily requirement = 1 mmol/kg• Dietary K+ < 25 mmol (1gram)/day leads to

hypokalaemia• Is magnesium low (< 0.5 mmol/L)?

(makes it difficult to correct potassium)

Page 42: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Causes of Hypokalaemia

• Potential sites for K+ loss- urine; faeces; drain sites; vomitus

• Intracellular shifts- insulin- β adrenoceptor agonists- caffeine- hyperthyroidism- correction of acidosis

• Increased external losses- Drugs that promote renal K+ excretion

loop diuretics (eg frusemide) aldosterone; thiazides; penicillins

Page 43: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Potassium Replacement• There is no single way to correct potassium• serum K+ of 0.3 mmol/L = overall deficiency

100 mmol K+ (but extremely variable)• Replace with oral supplements where possible• Ideally, correction of potassium should occur over a

period of days• Account for deficit + ongoing normal requirements

Page 44: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Case Study - Mr KCl

• 72 y.o. ♂• Med Hx: hypertension, heart failure• Rx: frusemide 80mg mane; lisinopril 10mg mane;

amlodipine 10mg mane• Admitted for elective TKR• Pre-op serum potassium: 2.9 mmol/L• Registrar:

- “Give him some IV KCl and fluids pre-op”- suggests 40 mmol in 100mL N Sal over 60 min

- What happened?

Page 45: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Potassium Administration

• In non critical care cases, Should NOT give KCL > 10 mmol/hour WITHOUT a pump

• With a pump max. rate = 20 mmol/hour• Concentrations > 40 mmol/L: risk causing

thrombophlebitis, pain and loss of IV site • If via central line, concentration NOT a concern,

but RATE is!

Page 46: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Causes of Hyperkalaemia

• ↓ K+ excretion (renal insufficiency)• ↑ K+ intake (but rapid K+ excretion 2o to ↑ intake) • K+ release from cells• Metabolic acidoses• Medications• Hypoaldosteronism/resistance to aldosterone

Page 47: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Managing Hyperkalaemia

– What are your aims?– What are the risks? – What do you do?– How do you do it?

Page 48: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Cardiovascular Protection

Calcium Gluconate by slow IV push

–decreases membrane excitability–10 mL of 10% calcium gluconate (2.2 mmol)–onset 2-5 minutes, lasts up to an hour–can repeat if no ∆ ECG after 5-10 minutes

Page 49: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Shift Intravascular → Intracellular

• Insulin- 10 units insulin in 50 mL of 50% glucose- via syringe or free running drip- onset 15-30 minutes, lasts 1-3 hours-↓ plasma K+ by 0.5-1.5 mmol/L

• Nebulised salbutamol- 5 mg- onset within 30 minutes, lasts 2-4 hours-↓ plasma K+ by 0.5-1.5 mmol/L

Page 50: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Removing Excess Potassium

• Resonium® A (sodium polystyrene sulfonate)- promotes exchange of Na+ for K+ in the GIT - 30g orally or 60g enema mixed with glucose- onset within 2 hours, peak effect at 6 hours- 1 gram binds 1 mmol K+ and releases 2-3 mmol Na+

- generally lowers plasma K+ by 0.5-1.0 mmol/L- can give up to 4 doses per day (as per levels)

• Haemodialysis- severe life-threatening hyperkalaemia unresponsive

to more conservative measures

Page 51: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Sodium Replacement

• Consider- ? over filling (heart, renal, liver failure) - ? over diuresis - ? SIADH – SSRIs; TCAs; carbamazepine

• Replace Na+ gradually (↑ plasma Na+ by ≤ 10 mmol/L/day)• Na+ required to ↑ plasma Na+ by 10 mmol/L:

[0.6 * total body weight (kg)] * 10 = x mmol/L Na+

NEVER attempt to replace sodium with hypertonic saline!- IRREVERSIBLE osmotic demyelination of CNS

(several cases in QLD in recent years)

Page 52: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Magnesium

• Indications- hypomagnesaemia - post MI- antiarrythmic- acute asthma- pre-eclampsia

• Oral - limited value (laxative)• Be aware of IV rate - vasodilator!

Page 53: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Key Messages

• Use oral route for electrolytes if possible• Significant patient harm 2° to rapid/concentrated KCl• K+ reduction - protect heart (short and long term)• NO place for hypertonic saline – demyelenitaion risk• Magnesium used for hypertension

Page 54: Safe Prescribing Week 3 – Amino glycosides + electrolytes Dr Ian Coombes, Senior Clinical Lecturer University of Queensland Schools of Medicine and Pharmacy

Questions?